Optimization of Clonazepam Therapy Adjusted to Patient’s CYP3A Status and NAT2 Genotype

BACKGROUND: The shortcomings of clonazepam therapy include tolerance, withdrawal symptoms, and adverse effects such as drowsiness, dizziness, and confusion leading to increased risk of falls. Inter-individual variability in the incidence of adverse events in patients partly originates from the diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tóth, Katalin, Csukly, Gábor, Sirok, Dávid, Belic, Ales, Kiss, Ádám, Háfra, Edit, Déri, Máté, Menus, Ádám, Bitter, István, Monostory, Katalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Regular Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203763/
https://www.ncbi.nlm.nih.gov/pubmed/27639091
http://dx.doi.org/10.1093/ijnp/pyw083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203763/
https://www.ncbi.nlm.nih.gov/pubmed/27639091
http://dx.doi.org/10.1093/ijnp/pyw083

Ejemplares similares